Pizotifen (Sanomigran) in Childhood Migraine

Authors:
  • DGDouglas Gillies
    Douglas Gillies
  • MSMichael Sills
    Michael Sills
  • IFIan Forsythe
    Ian Forsythe

Abstract
Forty-seven children with migraine have been included in a double-blind crossover study with pizotifen and placebo. The children received either pizotifen for 3 months followed by placebo or vice versa. Thirty-nine children completed the trial and there was no significant difference between active and placebo treatment as regards reduction of number of attacks, total and mean duration of attacks and duration of longest attacks. Pizotifen was well tolerated by the children.